Loading...
Clarivate PLC (CLVT) is not a good buy for a beginner, long-term investor at this time. The stock exhibits weak technical indicators, poor financial performance, and negative sentiment from analysts. While hedge funds are increasing their positions, the company's growth prospects are limited, and there are no strong positive catalysts to justify a buy decision.
The stock is in a bearish trend with the MACD histogram below zero (-0.0594) and negatively contracting. The RSI of 16.439 indicates the stock is oversold, but the moving averages (SMA_200 > SMA_20 > SMA_5) confirm a bearish outlook. Key support is at 1.835, and resistance is at 2.202. The stock is trading close to its support level, but no reversal signals are evident.

Hedge funds are increasing their positions, with a 182.82% rise in buying activity over the last quarter. The stock is oversold based on RSI, which could attract short-term interest.
Analysts have downgraded the stock due to slow revenue growth, competition from AI-native entrants, and limited pricing power. Financial performance in Q3 2025 showed a significant decline in net income (-56.86% YoY) and EPS (-55.56% YoY). Gross margin also dropped by 9.40% YoY. No recent news or congress trading data supports a positive outlook.
In Q3 2025, revenue increased marginally by 0.14% YoY to $623.1M. However, net income dropped significantly to -$28.3M (-56.86% YoY), EPS fell to -0.04 (-55.56% YoY), and gross margin declined to 34.2% (-9.40% YoY). Overall, the financial performance indicates a struggling company with declining profitability.
Goldman Sachs downgraded the stock to Neutral with a price target of $3.60, citing slow revenue growth and competition. Morgan Stanley downgraded it to Underweight with a price target of $3, highlighting continued underperformance and limited strategic value. Analyst sentiment is negative, with no recent upgrades or positive revisions.